"10.1371_journal.pone.0118497","plos one","2015-02-23T00:00:00Z","Kimberley A Pitman; Stephanie L Borgland; Bernard MacLeod; Ernest Puil","Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada","Conceived and designed the experiments: KP SLB BM EP. Performed the experiments: KP. Analyzed the data: KP SLB. Contributed reagents/materials/analysis tools: EP BM. Wrote the paper: KP SLB.","B.M and E.P have a patent application titled “Isovaline for the treatment of pain” (Patent number: US8278355 B2). E.P. is the chief executive officer and B.M is on the board of directors of TherExcell Pharma Inc. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","02","Kimberley A Pitman","KAP",4,TRUE,4,1,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
